全文获取类型
收费全文 | 4904篇 |
免费 | 388篇 |
国内免费 | 2篇 |
出版年
2023年 | 24篇 |
2022年 | 37篇 |
2021年 | 86篇 |
2020年 | 52篇 |
2019年 | 72篇 |
2018年 | 82篇 |
2017年 | 76篇 |
2016年 | 139篇 |
2015年 | 266篇 |
2014年 | 272篇 |
2013年 | 278篇 |
2012年 | 443篇 |
2011年 | 401篇 |
2010年 | 260篇 |
2009年 | 227篇 |
2008年 | 300篇 |
2007年 | 294篇 |
2006年 | 271篇 |
2005年 | 267篇 |
2004年 | 256篇 |
2003年 | 250篇 |
2002年 | 234篇 |
2001年 | 48篇 |
2000年 | 26篇 |
1999年 | 66篇 |
1998年 | 65篇 |
1997年 | 40篇 |
1996年 | 39篇 |
1995年 | 45篇 |
1994年 | 48篇 |
1993年 | 32篇 |
1992年 | 27篇 |
1991年 | 23篇 |
1990年 | 16篇 |
1989年 | 24篇 |
1988年 | 13篇 |
1987年 | 23篇 |
1986年 | 11篇 |
1985年 | 13篇 |
1984年 | 16篇 |
1983年 | 26篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 10篇 |
1979年 | 17篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1972年 | 4篇 |
排序方式: 共有5294条查询结果,搜索用时 62 毫秒
921.
Quantification of cytosolic interactions identifies Ede1 oligomers as key organizers
of endocytosis 下载免费PDF全文
Dominik Boeke Susanne Trautmann Matthias Meurer Malte Wachsmuth Camilla Godlee Michael Knop Marko Kaksonen 《Molecular systems biology》2014,10(11)
Clathrin-mediated endocytosis is a highly conserved intracellular trafficking pathway that
depends on dynamic protein–protein interactions between up to 60 different proteins. However,
little is known about the spatio-temporal regulation of these interactions. Using fluorescence
(cross)-correlation spectroscopy in yeast, we tested 41 previously reported interactions in
vivo and found 16 to exist in the cytoplasm. These detected cytoplasmic interactions
included the self-interaction of Ede1, homolog of mammalian Eps15. Ede1 is the crucial scaffold for
the organization of the early stages of endocytosis. We show that oligomerization of Ede1 through
its central coiled coil domain is necessary for its localization to the endocytic site and we link
the oligomerization of Ede1 to its function in locally concentrating endocytic adaptors and
organizing the endocytic machinery. Our study sheds light on the importance of the regulation of
protein–protein interactions in the cytoplasm for the assembly of the endocytic machinery
in vivo. 相似文献
922.
Chandra Sekhar Reddy Chilamakuri Susanne Lorenz Mohammed-Amin Madoui Daniel Vodák Jinchang Sun Eivind Hovig Ola Myklebost Leonardo A Meza-Zepeda 《BMC genomics》2014,15(1)
Background
Recent developments in deep (next-generation) sequencing technologies are significantly impacting medical research. The global analysis of protein coding regions in genomes of interest by whole exome sequencing is a widely used application. Many technologies for exome capture are commercially available; here we compare the performance of four of them: NimbleGen’s SeqCap EZ v3.0, Agilent’s SureSelect v4.0, Illumina’s TruSeq Exome, and Illumina’s Nextera Exome, all applied to the same human tumor DNA sample.Results
Each capture technology was evaluated for its coverage of different exome databases, target coverage efficiency, GC bias, sensitivity in single nucleotide variant detection, sensitivity in small indel detection, and technical reproducibility. In general, all technologies performed well; however, our data demonstrated small, but consistent differences between the four capture technologies. Illumina technologies cover more bases in coding and untranslated regions. Furthermore, whereas most of the technologies provide reduced coverage in regions with low or high GC content, the Nextera technology tends to bias towards target regions with high GC content.Conclusions
We show key differences in performance between the four technologies. Our data should help researchers who are planning exome sequencing to select appropriate exome capture technology for their particular application.Electronic supplementary material
The online version of this article (doi:10.1186/1471-2164-15-449) contains supplementary material, which is available to authorized users. 相似文献923.
Anke Schwarzenberger Thomas Sadler Susanne Motameny Kamel Ben-Khalifa Peter Frommolt Janine Altmüller Kathryn Konrad Eric von Elert 《BMC genomics》2014,15(1)
Background
Cyanobacteria constitute a serious threat to freshwater ecosystems by producing toxic secondary metabolites, e.g. microcystins. These microcystins have been shown to harm livestock, pets and humans and to affect ecosystem service and functioning. Cyanobacterial blooms are increasing worldwide in intensity and frequency due to eutrophication and global warming. However, Daphnia, the main grazer of planktonic algae and cyanobacteria, has been shown to be able to suppress bloom-forming cyanobacteria and to adapt to cyanobacteria that produce microcystins. Since Daphnia’s genome was published only recently, it is now possible to elucidate the underlying molecular mechanisms of microcystin tolerance of Daphnia.Results
Daphnia magna was fed with either a cyanobacterial strain that produces microcystins or its genetically engineered microcystin knock-out mutant. Thus, it was possible to distinguish between effects due to the ingestion of cyanobacteria and effects caused specifically by microcystins. By using RNAseq the differentially expressed genes between the different treatments were analyzed and affected KOG-categories were calculated. Here we show that the expression of transporter genes in Daphnia was regulated as a specific response to microcystins. Subsequent qPCR and dietary supplementation with pure microcystin confirmed that the regulation of transporter gene expression was correlated with the tolerance of several Daphnia clones.Conclusions
Here, we were able to identify new candidate genes that specifically respond to microcystins by separating cyanobacterial effects from microcystin effects. The involvement of these candidate genes in tolerance to microcystins was validated by correlating the difference in transporter gene expression with clonal tolerance. Thus, the prevention of microcystin uptake most probably constitutes a key mechanism in the development of tolerance and adaptation of Daphnia. With the availability of clear candidate genes, future investigations examining the process of local adaptation of Daphnia populations to microcystins are now possible.Electronic supplementary material
The online version of this article (doi:10.1186/1471-2164-15-776) contains supplementary material, which is available to authorized users. 相似文献924.
Michael Gejl Susanne Lerche Annette Mengel Niels M?ller Bo Martin Bibby Kamille Smidt Birgitte Brock Hanne S?ndergaard Hans Erik B?tker Albert Gjedde Jens Juul Holst S?ren Baarsgaard Hansen J?rgen Rungby 《PloS one》2014,9(1)
Background and Aims
Glucagon-like peptide-1 (GLP-1) may provide beneficial cardiovascular effects, possibly due to enhanced myocardial energetic efficiency by increasing myocardial glucose uptake (MGU). We assessed the effects of GLP-1 on MGU in healthy subjects during normo- and hypoglycemia.Materials and Methods
We included eighteen healthy men in two randomized, double-blinded, placebo-controlled cross-over studies. MGU was assessed with GLP-1 or saline infusion during pituitary-pancreatic normo- (plasma glucose (PG): 4.5 mM, n = 10) and hypoglycemic clamps (PG: 3.0 mM, n = 8) by positron emission tomography with 18fluoro-deoxy-glucose (18F-FDG) as tracer.Results
In the normoglycemia study mean (± SD) age was 25±3 years, and BMI was 22.6±0.6 kg/m2 and in the hypoglycemia study the mean age was 23±2 years with a mean body mass index of 23±2 kg/m2. GLP-1 did not change MGU during normoglycemia (mean (+/− SD) 0.15+/−0.04 and 0.16+/−0.03 µmol/g/min, P = 0.46) or during hypoglycemia (0.16+/−0.03 and 0.13+/−0.04 µmol/g/min, P = 0.14). However, the effect of GLP-1 on MGU was negatively correlated to baseline MGU both during normo- and hypoglycemia, (P = 0.006, r2 = 0.64 and P = 0.018, r2 = 0.64, respectively) and changes in MGU correlated positively with the level of insulin resistance (HOMA 2IR) during hypoglycemia, P = 0.04, r2 = 0.54. GLP-1 mediated an increase in circulating glucagon levels at PG levels below 3.5 mM and increased glucose infusion rates during the hypoglycemia study. No differences in other circulating hormones or metabolites were found.Conclusions
While GLP-1 does not affect overall MGU, GLP-1 induces changes in MGU dependent on baseline MGU such that GLP-1 increases MGU in subjects with low baseline MGU and decreases MGU in subjects with high baseline MGU. GLP-1 preserves MGU during hypoglycemia in insulin resistant subjects.ClinicalTrials.gov registration numbers: : (hypoglycemia) and NCT00418288: (normoglycemia). NCT00256256相似文献925.
Bence Szalai Péter Hoffmann Susanne Prokop László Erdélyi Péter Várnai László Hunyady 《PloS one》2014,9(10)
G Protein Coupled Receptors (GPCR) can form dimers or higher ordered oligomers, the process of which can remarkably influence the physiological and pharmacological function of these receptors. Quantitative Bioluminescence Resonance Energy Transfer (qBRET) measurements are the gold standards to prove the direct physical interaction between the protomers of presumed GPCR dimers. For the correct interpretation of these experiments, the expression of the energy donor Renilla luciferase labeled receptor has to be maintained constant, which is hard to achieve in expression systems. To analyze the effects of non-constant donor expression on qBRET curves, we performed Monte Carlo simulations. Our results show that the decrease of donor expression can lead to saturation qBRET curves even if the interaction between donor and acceptor labeled receptors is non-specific leading to false interpretation of the dimerization state. We suggest here a new approach to the analysis of qBRET data, when the BRET ratio is plotted as a function of the acceptor labeled receptor expression at various donor receptor expression levels. With this method, we were able to distinguish between dimerization and non-specific interaction when the results of classical qBRET experiments were ambiguous. The simulation results were confirmed experimentally using rapamycin inducible heterodimerization system. We used this new method to investigate the dimerization of various GPCRs, and our data have confirmed the homodimerization of V2 vasopressin and CaSR calcium sensing receptors, whereas our data argue against the heterodimerization of these receptors with other studied GPCRs, including type I and II angiotensin, β2 adrenergic and CB1 cannabinoid receptors. 相似文献
926.
Diana Pauly Benedikt M. Nagel J?rg Reinders Tobias Killian Matthias Wulf Susanne Ackermann Boris Ehrenstein Peter F. Zipfel Christine Skerka Bernhard H. F. Weber 《PloS one》2014,9(5)
The complement system is an essential part of the innate immune system by acting as a first line of defense which is stabilized by properdin, the sole known positive regulator of the alternative complement pathway. Dysregulation of complement can promote a diversity of human inflammatory diseases which are treated by complement inhibitors. Here, we generated a novel blocking monoclonal antibody (mAb) against properdin and devised a new diagnostic assay for this important complement regulator. Mouse mAb 1340 specifically detected native properdin from human samples with high avidity. MAb 1340 inhibited specifically the alternative complement mediated cell lysis within a concentration range of 1–10 µg/mL. Thus, in vitro anti-properdin mAb 1340 was up to fifteen times more efficient in blocking the complement system as compared to anti-C5 or anti-Ba antibodies. Computer-assisted modelling suggested a three-dimensional binding epitope in a properdin-C3(H2O)-clusterin complex to be responsible for the inhibition. Recovery of properdin in a newly established sandwich ELISA using mAb 1340 was determined at 80–125% for blood sample dilutions above 1∶50. Reproducibility assays showed a variation below 25% at dilutions less than 1∶1,000. Systemic properdin concentrations of healthy controls and patients with age-related macular degeneration or rheumatic diseases were all in the range of 13–30 µg/mL and did not reveal significant differences. These initial results encourage further investigation into the functional role of properdin in the development, progression and treatment of diseases related to the alternative complement pathway. Thus, mAb 1340 represents a potent properdin inhibitor suitable for further research to understand the exact mechanisms how properdin activates the complement C3-convertase and to determine quantitative levels of properdin in biological samples. 相似文献
927.
928.
929.
930.
Migrating birds perform extraordinary endurance flights, up to 200 h non-stop, at a very high metabolic rate and while fasting. Such an intense and prolonged physical activity is normally associated with an increased production of reactive oxygen and nitrogen species (RONS) and thus increased risk of oxidative stress. However, up to now it was unknown whether endurance flight evokes oxidative stress. We measured a marker of oxidative damage (protein carbonyls, PCs) and a marker of enzymatic antioxidant capacity (glutathione peroxidase, GPx) in the European robin (Erithacus rubecula), a nocturnal migrant, on its way to the non-breeding grounds. Both markers were significantly higher in European robins caught out of their nocturnal flight than in conspecifics caught during the day while resting. Independently of time of day, both markers showed higher concentrations in individuals with reduced flight muscles. Adults had higher GPx concentrations than first-year birds on their first migration. These results show for the first time that free-flying migrants experience oxidative stress during endurance flight and up-regulate one component of antioxidant capacity. We discuss that avoiding oxidative stress may be an overlooked factor shaping bird migration strategies, e.g. by disfavouring long non-stop flights and an extensive catabolism of the flight muscles. 相似文献